Vinpocetine reduces lipid accumulation in adipocytes
Cell-based study · 3T3-L1 cells [1]
In 3T3-L1 cells, Vinpocetine treatment at 50 μg/ml and 100 μg/ml was evaluated using spectrophotometry. Vinpocetine-treated adipocytes had 40% less lipid accumulation than dimethyl sulfoxide-treated control adipocytes.
| Endpoint | Reported result | Reference |
|---|---|---|
| Lipid accumulation in 3T3-L1 cells was measured using spectrophotometry | lipid accumulation 50 and 100 μg/ml; at 2 days after MDI treatment; 6 days after MDI treatment: 40% less lipid accumulation | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 50 μg/ml and 100 μg/ml
- Exposure duration
- at 2 days after MDI treatment; 6 days after MDI treatment
- Vehicle
- dimethyl sulfoxide
- Co-treatment
- Other interventions in this design: insulin 1 μg/ml; isobutylmethylxanthine 520 μM; dexamethasone 1 μM. Compound effect isolated by the comparison: dimethyl sulfoxide-treated control adipocytes.
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: Vinpocetine
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > Cell culture (S6, S7); Materials and methods > ORO staining (S22); Results > Vinpocetine inhibits the differentiation of 3T3-L1 cells and the expression of adipogenesis-associated factors (S41, S42, S50, S54, S55)
Lipid accumulation in 3T3-L1 cells was measured using spectrophotometry: Lipid accumulation in 3T3-L1 cells was measured using spectrophotometry; comparator: dimethyl sulfoxide-treated control adipocytes — Results > Vinpocetine inhibits the differentiation of 3T3-L1 cells and the expression of adipogenesis-associated factors (S41, S42, S50, S54, S55)